Faheem Tahir
Sun, April 12, 2026 astatine 4:45 PM CDT 2 min read
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is featured successful our database of the best penny stocks acceptable to explode.
As of April 8, 2026, expert sentiment toward Neumora Therapeutics, Inc. (NASDAQ:NMRA) remains bullish, with 78% of analysts assigning a “Buy” standing to the stock. The statement terms people of $8 implies a imaginable upside of 275.59%.
Reinforcing this constructive sentiment, connected March 31, 2026, Guggenheim reiterated its “Buy” standing with a $14 terms people connected the stock. This improvement followed the company’s fourth-quarter 2025 results and pipeline update.
On March 30, 2026, Neumora Therapeutics, Inc. (NASDAQ:NMRA) highlighted important advancement successful a fig of programs, including the completion of enrollment successful 2 late-stage navacaprant studies, which are expected to output results successful Q2 2026, and the receipt of affirmative aboriginal objective signals for NMRA-898 successful schizophrenia. Additionally, the institution reported encouraging Phase 1b information for NMRA-511 successful Alzheimer’s illness agitation.
Moreover, the institution provided investors with an update connected NMRA-215 successful obesity, wherever affirmative preclinical grounds was counterbalanced by unexpected toxicological findings that are presently being reevaluated. Neumora Therapeutics, Inc. (NASDAQ:NMRA) reported that it had $182.5 cardinal successful currency astatine the extremity of 2025, with the company’s runway expected to widen until Q3 2027. This superior volition beryllium utilized to enactment aggregate near-term pipeline catalysts.
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is simply a clinical-stage biopharmaceutical institution that specializes successful processing targeted therapies for analyzable neuropsychiatric and neurodegenerative conditions. These scope from large depressive upset to Alzheimer’s and Parkinson’s. By focusing connected the subject of the cardinal tense system, they purpose to supply life-changing solutions for those facing intelligence wellness and neurological challenges.
While we admit the imaginable of NMRA arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.
Disclosure: None. Follow Insider Monkey connected Google News.

2 weeks ago
6





English (CA) ·
English (US) ·
Spanish (MX) ·